Sultamicillin is an oral mutual prodrug composed of:
∙ Ampicillin – a broad-spectrum penicillin-type β-lactam antibiotic
∙ Sulbactam – a β-lactamase inhibitor
Sultamicillin is designed to improve oral absorption and bioavailability of both components. Once ingested, it is hydrolyzed in the body to release ampicillin and sulbactam, which act synergistically to treat β-lactamase-producing bacterial infections.
It is commonly used to treat:
∙ Respiratory tract infections
∙ Urinary tract infections (UTIs)
∙ Skin and soft tissue infections
∙ Gynecological infections

Parent: Lisinopril / Tizanidine / Anastrozole / Sultamicillin
Parent: Sultamicillin / Ampicillin
Parent: Sultamicillin/ Sultamicillin Tosylate
Parent: Sultamicillin
Impurities in sultamicillin can arise from the synthetic process, storage conditions, or degradation, and must be controlled in line with ICH Q3A/B and pharmacopeial standards.
Process-Related Impurities
Degradation Impurities
Elemental Impurities
Analytical Techniques for Impurity Detection
Sultamicillin is used to treat:
Yes. Sultamicillin offers:
Common side effects include:
Rare but serious reactions: